Close Menu

NEW YORK – Medical device company Magnolia Medical announced Thursday a collaboration with Cardinal Health to distribute Magnolia's Steripath Gen2 Initial Specimen Diversion Device, which works to reduce blood culture contamination.

Cardinal Health will offer the device to hospitals as a standalone product or as part of a customizable best practice kit, with the goal of reducing false-positive diagnostic results for sepsis from blood contamination.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.